Provided by Tiger Fintech (Singapore) Pte. Ltd.

DexCom

66.11
-2.4600-3.59%
Post-market: 66.03-0.0800-0.12%17:47 EDT
Volume:4.02M
Turnover:265.01M
Market Cap:25.92B
PE:46.42
High:68.12
Open:68.07
Low:65.11
Close:68.57
Loading ...

DexCom Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
1 hour ago

Diabetes Device Makers' Shares Down After Eli Lilly's Pill Leads to Weight Loss in Late-Stage Trial

THOMSON REUTERS
·
17 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Plug Power, Snap-On

Reuters
·
17 Apr

BUZZ-Diabetes device makers fall after data on Lilly's weight loss pill

Reuters
·
17 Apr

Diabetes Device Maker Dexcom Shares Down 3.1% Premarket After Lilly's Pill Leads to Weight Loss in Late-Stage Trial

THOMSON REUTERS
·
17 Apr

ADVISORY-Alert on DexCom from law firm's press release withdrawn

Reuters
·
16 Apr

RBC Cuts Price Target on DexCom to $100 From $115, Keeps Outperform Rating

MT Newswires Live
·
15 Apr

DexCom Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
15 Apr

Tap Into the Silver Economy Boom With These Aging Demographics Stocks

Zacks
·
15 Apr

DexCom price target lowered to $107 from $120 at BTIG

TIPRANKS
·
14 Apr

DexCom Shares May Rise as G7 15-Day CGM System Gets FDA Clearance

Zacks
·
12 Apr

Dexcom’s G7 Sensor Approval and Strategic Moves Drive Buy Rating

TIPRANKS
·
11 Apr

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM) and Amgen (AMGN)

TIPRANKS
·
11 Apr

FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch

Benzinga
·
11 Apr

BUZZ-U.S. STOCKS ON THE MOVE-AppLovin, Ligand Pharma, Dexcom

Reuters
·
11 Apr

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

Reuters
·
11 Apr

DexCom Stock Rises as Glucose Monitoring System Gets FDA Clearance -- Barrons.com

Dow Jones
·
10 Apr

DexCom Says G7 15 Day Continuous Glucose Monitoring System Gets US FDA Clearance

MT Newswires Live
·
10 Apr

DexCom Shares Rise in Premarket on FDA Clearance for Glucose Monitoring System

Dow Jones
·
10 Apr

BUZZ-Dexcom rises as FDA clears use of its 15-day continuous glucose monitor

Reuters
·
10 Apr